William Blair Investment Management, LLC Blueprint Medicines Corp Transaction History
William Blair Investment Management, LLC
- $39 Billion
- Q3 2024
A detailed history of William Blair Investment Management, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, William Blair Investment Management, LLC holds 1,674,799 shares of BPMC stock, worth $152 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
1,674,799
Previous 1,593,916
5.07%
Holding current value
$152 Million
Previous $172 Million
9.86%
% of portfolio
0.4%
Previous 0.47%
Shares
16 transactions
Others Institutions Holding BPMC
# of Institutions
351Shares Held
60.3MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$605 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$601 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$487 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$359 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$250 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.4B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...